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ABSTRAK 
 
Tujuan dari penelitian ini adalah untuk menghitung jumlah apoptosis bone lining cells setelah pemberian glukokortikoid jangka 
panjang. Penelitian ini menggunakan Rattus norvegicus perempuan berusia 3 bulan yang dibagi menjadi 3 kelompok, masing-
masing kelompok terdiri dari 7 ekor tikus. Kelompok-kelompok tersebut adalah: (1) kelompok kontrol, (2) kelompok perlakuan 1 
diberi glukokortikoid 0,01 mg/hari, (3) kelompok perlakuan 2 diberi glukokortikoid 0,2 mg/hari. Pengobatan dilakukan selama 4 
minggu dan pada akhir pengobatan, tikus dikorbankan dan dilanjutkan dengan persiapan, dan jumlah bone lining cells yang 
mengalami apoptosis dihitung melalui pemeriksaan bagian metafisis jaringan tulang femur menggunakan teknik imunohistokimia. 
Semua data dianalisis dengan analisis statistik Anova. Hasil penelitian menunjukkan bahwa jumlah sel-sel tulang yang melapisi 
apoptosis meningkat pada kelompok dengan pemberian glukokortikoid 0,01 mm /hari dan 0,2 mg/hari dibandingkan dengan 
kelompok kontrol dengan p= 0,000 (p<0,05). Jumlah bone lining cells yang apoptosis pada kelompok glukokortikoid dosis 0,2 
mg/hari lebih tinggi daripada kelompok dosis glukokortikoid 0,01 mg/hari dengan p = 0,000 (p<0,05). Kesimpulannya pemberian 
jangka panjang glukokortikoid meningkatkan apoptosis dari bone lining cells.(FMI 2012;48:12-16) 
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ABSTRACT 
 
The aim of this study was to count the amount of apoptotic bone lining cells after long term glucocorticoid distribution. This study 
used Rattus Norvegicus females aged 3 months that were divided into 3 groups, each group consisted of 7 rats. The groups are: (1) 
control group; (2) treatment group 1 were given glucocorticoid 0,01 mg/day; (3) treatment group 2 were given glucocorticoid 
0,2mg/day. The treatment carried out for 4 weeks and at the end of treatment, mice were sacrified and continued with preparation, 
and the number of bone lining cells that undergoing apoptosis was calculated through examination of the femur bone tissue 
metaphysis section using immunohistochemical technique. All data were analyzed with statistical analysis Anova. The result showed 
that the number of apoptotic bone lining cells is increased in group with glucocorticoid administration 0.01 mg/day and 0.2 mg/day 
compared to control group with p= 0.000 (p <0.05). The number of apoptotic bone lining cells on the group of glucocorticoid dose 
0.2 mg/day higher than the group of glucocorticoid dose 0.01 mg/day with p= 0.000 (p <0.05). In conclusions long term 
glucocorticoid distribution increase apoptosis of bone lining cells.(FMI 2012;48:12-16) 
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INTRODUCTION 
 
Glucocorticoids are produced and released by the 
adrenal glands as response to stress and regulates 
several physiological processes network. Among others, 
these hormones cause immunosuppression and anti- 
inflammatory action and affect apoptosis multiple cell 
types include T-lymphocytes and monocytes. Therefore, 
glucocorticoids are widely used in medicine as 
therapeutic immune system and inflammatory 
processes. Glucocorticoid therapy may save the patient's 
life but in the long -term use will cause side effects that 
can be life threatening, one of which is the loss of bone 
fracture risk (Adler & Hochberg 2003, Dvorak et al 
2006). 
 
Bone is a specialized connective tissue that make up the 
tissues and organ systems, serves as a means of motion, 
protection, and mineral homeostasis. Consists of four 
cells are osteoblasts, osteocytes, bone lining cells, and 
osteoclasts. Bone lining cells derived from 
mesenchymal stem cells or cells osteoprogenitor, which 
is a relatively inactive form of osteoblast cells as 
"resting cells of osteoblasts". Other researchers reported 
that bone lining cells may be the precursors of 
osteoblasts that regulate the growth of bone crystals or 
as a barrier between the extracellular fluid and bones 
(Downey & Siegel 2006, Datta et al 2008, Lorenzo et al 
2008). Each organ get spare cells from stem cells, such 
as muscle satellite cells, basal cells of the skin and 
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lining cells on the bone. In the event of damage or 
apoptosis then any manipulation will not be able to fix 
up the cells so that the number will decrease. Similarly 
with bone, if the bone lining cells is reduced due to 
increased apoptosis of the backup process for the 
formation of bone cells will decrease the risk for an 
increased risk of fractures. Epidemiological data 
indicate that glucocorticoid therapy increases the risk of 
hip fractures and distal radius doubled and quadrupled 
spine. This is due to the provision of long- term 
glucocorticoid therapy causes rapid bone loss and 
weight resulting in increased risk of bone fractures. 
From the analysis of the General Practice Research 
Database (UK) on Veterans Affair Medical Centers, 
from 40 % patients with respiratory disease who 
received glucocorticoid therapy with an increased daily 
dose found an increased relative risk of fracture of the 
femur and spine (Abu et al 2000, Adler & Hochberg 
2003, Takuma et al 2003, Jia et al 2006, Kim et al 2006, 
Swanson et al 2006, Lu et al 2007). Although it has 
been many laboratory studies about the effects of 
glucocorticoids on bone but the molecular mechanisms 
underlying the onset of decline in bone formation 
process described with increased apoptosis of bone-
lining cells, has not been disclosed. Based on these 
facts, the research will be conducted to prove whether 
long - term distribution of glucocorticoids externally 
will improve the process of apoptosis of bone lining 
cells. 
 
 
MATERIAL & METHODS 
 
This study is an experimental study to examine the 
causal relationship between the treatment outcome after 
treatment in a time period. In this study as the 
experimental unit is mice (Rattus norvegicus Wistar 
strain), female, age 3 months. The number of samples 
used is 21, divided into 3 groups: control group, 
treatment group 1 low-dose glucocorticoid distribution 
(0.01 mg/200 g body weight/day), treatment group 2 
high-dose glucocorticoid distribution (0.2 mg/200 g 
weight/day). The study was conducted for 4 weeks, then 
the mice were sacrificed for its femur and then doing 
preparation for immunohistochemistry. After that 
counting the number of bone-lining cells that undergo 
apoptosis, characterized by chromatin condensation and 
fragmentation of nuclei by immunohistochemistry 
(Weinstein et al 2000), calculate each microscopic point 
of view. 
 
 
RESULTS 
 
The data obtained from the studies of bone lining cells 
undergoing apoptosis due to low dose glucocorticoid 
distribution of 0.01 mg/200 g BB and high dose 
distribution 0.2 mg/200 g BB in the long term (4 weeks) 
were calculated based on test results on the 
metaphysical basis imunohistologis femur bone tissue. 
The higher the dose was given, the greater the number 
of cells undergoing apoptosis. These variables were 
tested by using a statistical test one way analysis of 
variance (one way anava), which aims to look at the 
effect of treatment between groups on the dependent 
variable. The results of the analysis of variance 
calculations show that there is a very significant 
difference, p = 0.000 (p <0.05). To find out where the 
different between groups, followed by a different test 
(multiple comparisons) through Post Hoc Tests  
 
Table 1. Results of different test variables between 
groups of apoptotic cells 
 
mGROUP p 
Control Dose 0.01 mg 
Dose 0.2 mg 
0.000 
0.000 
Dose 0.01 mg Dose 0.2 mg 0.000 
 
 
 
Figure 1.  The results of the analysis of the mean 
apoptotic cell groups 
   
The results of the analysis of variance calculations 
(Table 1), there are differences in bone lining cells 
undergoing apoptosis between the control group and the 
treatment group. Bone lining cells in mice that received 
0.2 mg dose glucocorticoid treatment experienced more 
apoptosis than 0.01 mg-dose glucocorticoids. Mice that 
received moderate-dose glucocorticoid treatment of 0.01 
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mg of bone-lining cells undergoing apoptosis greater 
than untreated mice (Figure 1).  
 
Immunohistochemistry in the control group showed that 
bone lining cells appear normal on the surface of 
trabecular bone (Figure 2). Immunohistochemical 
examination results in the group with administration of 
0.01 mg dose glucocorticoid Tunnel assay using cells 
undergoing apoptosis showed dark brown color changes 
to black in the cell nucleus that indicates the occurrence 
of DNA fragmentation (Figure 3). 
 
 
 
Figure 2. Bone-lining cells in the control group. X 400 
 
 
 
Figure 3.  Apoptosis of bone lining cells in the 0.01 mg 
group glucocorticoid administration. X400 
 
Overview immunohistochemistry using methods Tunnel 
assay for group glucocorticoid distribution 0.2 mg, cells 
undergoing apoptosis show a dark brown color changes 
to black in the cell nucleus that indicates the occurrence 
of DNA fragmentation. At the 0.2 mg group number of 
apoptotic bone-lining cells more than 0.01 mg group 
(Figure 4).  
 
 
 
Figure 4.  Apoptosis of bone lining cells in the 0.2 mg 
group glucocorticoid administration. X400 
 
 
DISCUSSION 
 
The objective from this study was to examine the causal 
relationship between treatment and treatment outcome 
after a time period. The treatment given to the 
experimental animals, in this study using drugs from 
glucocorticoid group that is Dexamethasone with low 
dose variation of 0.01 mg per 200 g body weight of rats 
and high dose of 0.2 mg per 200 g body weight of rat 
based dose calculation of conversion table of various 
animals and humans.  
Dexamethasone is used in this study is drugs from 
glucocorticoid group that easily available, cheap prices 
and a group of drugs commonly used in treatment in the 
community, especially for chronic diseases. Weinstein 
et al (2000), states that bone destruction occurs in 25 % 
of patients who received glucocorticoid treatment. 
Although it has been done before treatment observation 
of femoral head collapse and severe osteoporosis but an 
attempt to reduce the dose or discontinue treatment 
usually unsuccessful because of the need for 
glucocorticoid treatment, such as in patients with 
transplants, lung disease, arthritis, autoimmune, 
haemopoietic and gastrointestinal. Consequently, the 
patient will receive treatment in months, years and even 
throughout his life. 
 
Increased risk of bone damage with increasing dose and 
duration of treatment. In this study performed in a mice 
model of glucocorticoid distriution in long term that is 4 
weeks. According Suatmadji (2001), the mice who 
received glucocorticoids in 4 weeks equivalent to 3-4 
years in humans, showed a decrease in bone mineral 
density associated with a decrease in the number of 
osteoblasts, progenitor inside bone marrow, and 
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dramatic reduction in trabecular bone. These changes 
were associated with a significant reduction in osteoid 
area and reduced mineral apposition and bone 
formation. Glucocorticoids affect bone destruction 
through fat embolism, tampon de vascular on femoral 
caput blood vessels through the retention of fat or bone 
marrow fluid, another possibility is programmed cell 
death or apoptosis that are part of the mechanism of 
bone destruction. Weinstein et al (2000) reports mention 
that mice who received glucocorticoids for 4 weeks 
showed a threefold increase osteoblast apoptosis in 
vertebral cancellous bone and 28 % apoptosis of 
osteocytes in cortical bone metaphysis. 
 
Examination of apoptosis of bone lining cells using 
immunohistochemistry way through the Tunnel assay 
(terminal deoxyuridine nucleotide end labeling assay), a 
development examination of methods apoptosis through 
DNA fragmentation, which can overcome the detection 
difficulty of apoptosis by usual hematoxylin eosin 
staining. DNA fragments detected by enzymatic 
labeling of the end 3' nucleotides OH. Ends of the DNA 
fragments are found in the nucleus cells undergoing 
apoptosis and apoptotic bodies. Tunnel assay can detect 
early stages of apoptosis because DNA fragmentation 
occurs before the morphologic changes seen in 
histological preparations. Apoptosis usually occurs in 
groups of cells close to normal cells, appear on the 
picture with the cell nucleus condensation and 
chromatin fragmentation (Weinstein et al 2000). 
Counting the number of apoptotic cells in this study 
bone lining seen in the femur bone tissue. After the 
manufacture of femur tissue preparation, count the 
number of bone lining cells undergoing apoptosis. 
 
Animal body part being examined is the metaphysical 
part of the femur. Each type of bone consists of cortical 
and trabecular parts that have a certain proportion 
depending on the type of bone. In general, bone 
contains more trabecular bone that have a wider 
surfaces, so metabolic activity greater then when 
compared to cortical bone. Therefore, trabecular bone is 
more often experience changes, so have a tendency to 
shortage of bone mass. This is one reason why 
vertebrae, colloum femur and metaphysis of long bones 
are is a place that often experience fractures in people 
with osteoporosis. Based on research from, proved that 
these bones have significance to the variation in the 
structure and density of the bone tissue. Therefore, this 
study conducted checks on the femur metaphysis region, 
the area of ??the femur close to the femoral colloum 
where there is more trabecular bone than cortical bone, 
that has a higher metabolic capability, so it making easy 
to see changes in bone cell metabolism. 
 
In general, males and black skin have a higher bone 
density than women. While another study states that the 
levels of glucocorticoids (corticosterone) in women and 
animals higher than men. So in this study were selected 
mice that are animal which has many similarities with 
the human metabolism, thus chosen as the model of this 
study.3 -month -old mice with consideration that the age 
is adult age of animals, with the consideration that at 
adult age growth hormone effect is not as big as the 
effect of growth hormone during pre- adult age, so it 
does not much affect bone growth. 
 
According to Weinstein et al (2000), the long-term 
glucocorticoid will cause osteoblast apoptosis in 
patients with osteoporosis. Past research has shown that 
glucocorticoids work directly on the bone -forming cells 
(osteoblastic lineage) through the glucocorticoid 
receptor (GR?) on bone forming surface, where the 
remodeling process occurs in cultured osteocytes and 
osteoblasts (Abu et al 2000). Glucocorticoids modulate 
the activity of intracellular kinase Proline-rich tyrosine 
kinase 2 (Pyk2) members of the focal adhesion kinase 
(FAK) family of non- receptor tyrosine kinase. 
Although Pyk2 and FAK are highly homologous, but 
these proteins showed different effects on cell fate. FAK 
activation causing cell multiplication and cell defense, 
Pyk2 affect the reorganization of the cytoskeleton, cell 
damage and apoptosis (Park et al 2004, Plotkin et al 
2007). In the event of damage or apoptosis then any 
manipulation will not be able to fix the cells so that the 
number will decrease. Similarly to the bone, if the bone 
lining cells are reserve cells (resting cells of osteoblasts) 
is reduced due to an increase in the apoptotic process, 
the process of bone formation decreases with a decrease 
in bone density are at risk of osteoporosis. 
 
Osteoblasts are the cells that secrete organic matrix, 
place for precipitate calcium phosphate crystals 
(hydroxyapatite) which among other collagen as an 
ingredient that determines bone density (Sherwood 
2004). Meanwhile, according to Downey and Siegel 
(2006), the osteoblasts, osteocytes and bone lining cells 
derived from stem cells or mesensimal known as 
Osteoprogenitor. Osteoblasts development will follow 
three forms: (1) active osteoblasts, (2) surrounded by 
matrix become osteocytes, or (3) become relatively 
inactive and form bone lining cells. Based on this 
statement the long-term distribution of glucocorticoids 
can also occur at the cell bone lining from same given 
with osteoblasts. This study proves that long-term 
glucocorticoids distribution can lead to apoptosis in 
bone lining cells . 
 
Bone lining cells appear as flat form cells, thin, 
elongated, covering most of the surface of mature bone. 
Cytoplasmic protrusions or its gap junctions connected 
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each other or with osteocytes. Because having an 
inactive metabolism, bone lining cells contains fewer 
organelles and cytoplasm than osteoblasts. At one point 
bone lining cells will be "resting osteoblasts" or "surface 
osteocytes" (Downey & Siegel 2006). On this basis the 
results of this study can be said to be important because 
bone lining cells are reserve cells for osteoblasts. Long-
term glucocorticoid treatment causes apoptosis of 
osteoblasts and osteocytes (Weinstein et al 2000) and 
proved in this study, also occur in bone lining cells will 
further exacerbate the resulting decrease in bone 
density. Other researchers say that the bone lining cells 
as osteoblast precursors governing growth of crystal 
bone (hydroxyapatite) (Downey & Siegel 2006), then in 
the event of an increase apoptosis of bone lining cells, 
due to long- term glucocorticoids distribution, bone 
density will decrease. 
 
 
CONCLUSION 
 
Giving glucocorticoids 0.01 mg /day and 0.2 mg /day 
for four weeks in Rattus norvegicus will increase the 
number of apoptotic bone lining cells. Giving 
glucocorticoid dose 0.2 mg/day showed the number of 
apoptotic bone lining cells is higher than the dose of 
0.01 mg/day. 
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